Bioengineering
-
Mosaic receptor-binding domain nanoparticles induce protective immunity against SARS-CoV-2 challenges
This article has 20 authors:Reviewed by ScreenIT
-
Biomechanical Dependence of SARS-CoV-2 Infections
This article has 8 authors:Reviewed by ScreenIT
-
Engineering defensin α‐helix to produce high‐affinity SARS‐CoV ‐2 spike protein binding ligands
This article has 6 authors:Reviewed by ScreenIT
-
Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2
This article has 13 authors:Reviewed by ScreenIT
-
Human cardiac organoids to model COVID‐19 cytokine storm induced cardiac injuries
This article has 12 authors:Reviewed by ScreenIT
-
Genetically engineered insects with sex-selection and genetic incompatibility enable population suppression
This article has 7 authors:This article has been curated by 1 group:Reviewed by eLife
-
Nanoformulated Remdesivir with Extremely Low Content of Poly(2‐oxazoline)‐Based Stabilizer for Aerosol Treatment of COVID‐19
This article has 8 authors:Reviewed by ScreenIT
-
Targeting SARS-CoV-2 infection through CAR-T like bispecific T cell engagers incorporating ACE2
This article has 6 authors:Reviewed by ScreenIT
-
Immunokinetic Model for COVID-19 Patients
This article has 3 authors:Reviewed by ScreenIT
-
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape
This article has 23 authors:Reviewed by ScreenIT